Catalyst Wire Dossier Catalyst Wire Dossier

OG-6219

· Organon
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OG-6219, covering 2025-05-29 to 2025-05-29. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related Pain [Phase 2]

See pricing